AbCellera Biologics Inc.

Grantee website Vancouver, British Columbia, Canada
Purpose
to identify potent anti-RSV monoclonal antibodies to protect infants in low and middle income countries from RSV infection morbidity and mortality
Grantee
Division
Global Health
Date
JANUARY 2022
Region served
GLOBAL
Committed amount
$2,094,770
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
24
Grantee location
Vancouver, British Columbia, Canada
Related work

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.